Outcome of Board Meeting

Updated on: Dec 09, 2017

The Board of Directors, at their meeting today, approved the unaudited Financial Results (Stand-alone & Consolidated) for the Quarter / Six-month ended September 30, 2017, which are attached herewith, along with Limited Review Reports, pursuant to Regulation 33 (3) (a) to (c) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board has decided to defer a decision on interim dividend pending assessment of requirement of funds to meet the capex requirements of the wholly-owned subsidiary, Nueclear Healthcare Limited, since the Company has already decided to give them loan to help them acquire costly equipment like Cyclotron, PET-CT Scan machines, etc., to set up additional scanning centres; to invest upto Rs. 20 crores in Equinox Labs Private Limited, Navi Mumbai-Rs. 10 crores in cash and by divestment of Water Testing Business to them for Rs. 10 crores, on slump sale basis, and to administer the ESOP schemes hereafter directly instead of through the Trust.

Pdf Link: Outcome of Board Meeting

Source : BSE - www.bseindia.com

Published on March 13, 2018

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you